Background: Aging process represents the natural process, which cannot be obviated. It is caused by biological factor that goes naturally that influence the anatomical, biochemical and physiological changes. The natural changes contribute in falling on elderly. The objective of this study was to describe the falling prediction in elderly using Functional Gait Assessment. Method: This study used descriptive study design. The population was 48 elderly, with sample of 43 elderly involved by means of purposive sampling, taken according to inclusion criteria. The variable was falling prediction. The data were collected using Functional Gait Assessment and then were analyzed. Result: Forty-three elderly in Panti Werdha Wana Seraya (aged 60-103 years, with a mean of 77,48 ± 1,61) were included. The result showed that elderly had a high risk of falls. Functional Gait Assessment showed that 41 from 43 respondents scored

Background: Among the cause of the treatment failure in epilepsy, low adherence to prescribed medication is the principal cause of unsuccessful drug treatment. The aim of this study was to assess the level of adherence and the relations with quality of life among epilepsy patients in Denpasar. Method: Our research based on cross sectional design and conducted in neurology department of tertiary referral hospital in Denpasar. We used Morisky Medication Adherence Scale (MMAS) to measure level of adherence and World Health Organization (WHOQOL-BREF) questionnaire to assess quality of life (QOL) score. Results: On this research, we found 83 epilepsy patients who fulfilled eligibility criteria, there are 43 patients categorized as non-adherent and 39 patients belong to adherent. Based on the cross tabulation between characteristic of participants and adherence, we found that age and duration of therapy influence the adherence level of epilepsy patient (p value < 0.05). Epilepsy patients who adherent to the treatment have higher score of QOL than epilepsy patients who not adherent, especially on physical domain of QOL, the difference was statistically significant (p value < 0.05). Conclusion: Improving adherence is so important to improve the quality of life of epilepsy patients.

No abstract

Experts have speculated the potential of heparin administration as COVID-19 treatment modality, although scientific research regarding its effectivity, recommended dosage, and period are still minimal. This study aims to explore the capacity of LMWH as a medicament for COVID-19, in effort to provide scientific reference for further development of COVID-19 possible choice of treatment or medicament. A retrospective study was conducted in Udayana University Hospital, Bali, Indonesia. Data were sourced from laboratory-confirmed COVID-19 patients medical records during March 25 to July 31, 2020. Clinical, laboratory, treatment and use of LMWH data were reviewed and statistically processed.  42 patients we found Use of LMWH. The patient categorizes from moderate to severe COVID-19. 31 patients use of LMWH for prophylaxis and 11 patients use of LMWH for treatment. 7 patients were death in the hospital, and the other was survived. LMWH elevates coagulation dysfunction in COVID-19 patients. We believe that beneficial effects of LMWH as prophylaxis or treatment in COVID-19 patients.

No abstract